*Auriga Medical logo*
*   about Auriga   *   products   *   media centre   *   contact us   *   site map   ***   health care professionals   *   medical therapy companies  
*
**
**
*
*Overview
Quality and delivery
Business strategy
History
Leadership
*

Leadership

Uwe Beinlich

Business Manager

email: uwe.beinlich@aurigamedical.com

Uwe Beinlich is the Business Manager for Auriga Medical (TM) in North America. He has a Diploma in Engineering and has more than 25 years experience in the design and manufacture and use of sealed radiation sources used in Health Physics, Nuclear Medicine and Therapeutic applications. He launched and has been Business Manager of the Isotrak(TM) instrument calibration sources business while QSA was part of Amersham International plc. and was responsible for the addition of the C-Trak(TM) range of Sentinel Node Scintigraphy intra-operative probe devices into the product range. He has a strong background in the physics of radioactivity measurements and continues as a representative member of the Council on Ionizing Radiation Measurements and Standards (CIRMS) and liason with NIST.

Rainer Prüsse

European Sales and Marketing Manager

email: Rainer Prusse@aurigamedical.com

Rainer Prüsse is the Sales and Marketing Manager, Europe for Medical Therapy and Business Manager, Environmental Services. He has over 20 years experience working with radioactive products in the areas of waste management and product management, including five years in radiopharmaceutical products at Amersham Buchler and six years experience in radioimmunoassays at Kodak Diagnostik and Johnson and Johnson Clinical Diagnostics. Rainer is a member of the German Association of Diagnostics Manufacturers (VDGH).

Dr Uwe Schwarz

Project Manager, Y90

email: uwe.schwarz@aurigamedical.com

Dr Uwe Schwarz, MA, PhD is the project manager for Y90. He brings with him over 15 years experience in radiopharmaceutical research and production. Prior to joining AEA Technology QSA, he was Managing Director and Head of Production for the radiopharmaceutical company Altmann Therapie. He has a Ph.D and Masters in Chemistry from the University of Dresden, where he carried out extensive research in the radiopharmaceutical production of Y-90, and At-211, and enzymatic methods of radiolabelling antibodies via saccharide transfer.
***
*Delivering the power to heal© 2008 QSA Global  
Auriga Medical is a trademark of QSA Global  		*
***